Analyst consensus rating
Eton Pharmaceuticals Analyst Rating: none
Direct answer
Eton Pharmaceuticals's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $71.00.
Forecast evidence checked September 5, 2026.
Get free Eton Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $58.45
- Average price target
- $71.00
- High price target
- $76.00
- Low price target
- $68.00
- Low target gap
- +16.3%
- Target upside
- +21.5%
- High target gap
- +30%
- Target range width
- 13.7%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Eton Pharmaceuticals?
Eton Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $71.00.
How far are Eton Pharmaceuticals's low and high targets from the recorded price?
The low target implies +16.3%, while the high target implies +30%.
How many analysts are included in Eton Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is Eton Pharmaceuticals's target upside or downside calculated?
The average target of $71.00 is divided by the recorded price of $58.45, then one is subtracted to produce +21.5%. This does not guarantee a future return.
When was Eton Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.